反応式
[CH3:1][C:2]([C:4]1[CH:9]=[CH:8][C:7]([O:10][CH3:11])=[C:6]([OH:12])[CH:5]=1)=O.Cl.[N:14]1[O:15][N:16]=[C:17]2[CH:22]=[C:21]([CH2:23][O:24][NH2:25])[CH:20]=[CH:19][C:18]=12.N1C=CC=CC=1>C(O)C>[N:14]1[O:15][N:16]=[C:17]2[CH:22]=[C:21]([CH2:23][O:24][N:25]=[C:2]([C:4]3[CH:9]=[CH:8][C:7]([O:10][CH3:11])=[C:6]([OH:12])[CH:5]=3)[CH3:1])[CH:20]=[CH:19][C:18]=12参加物
実験手順
A solution of 3-hydroxy-4-methoxyacetophenone (0.070 g, 0.421 mmol), (benzo[c][1,2,5]oxadiazol-5-yl)methoxyamine hydrochloride (0.126 g, 0.625 mmol) and pyridine (0.16 ml, 1.98 mmol) in ethanol (6 ml) was stirred at reflux under nitrogen for 4 h and cooled to room temperature. The solution was concentrated to a yellow oil which was diluted with water. The resultant suspension was extracted with dichloromethane (×3). The combined organic phases were washed with water, dried over magnesium sulphate, filtered and concentrated to a yellow oil. The crude product was purified by column chromatography (SiO2), eluting with 8:2 petrol/ethyl acetate, to give a slightly sticky solid which was further triturated with petroleum spirit (40-60°), to give 1-(3-hydroxy-4-methoxyphenyl)ethanone-O -[(benzo[c][1,2,5]oxadiazol-5-yl)methyl]oxime (CP9-33) as a light yellow solid (0.119 g, 90%).
後処理
- temperatureat reflux under nitrogen for 4 h
- concentrationThe solution was concentrated to a yellow oil which
- additionwas diluted with water
- extractionThe resultant suspension was extracted with dichloromethane (×3)
- washThe combined organic phases were washed with water
- dry with materialdried over magnesium sulphate
- filtrationfiltered
- concentrationconcentrated to a yellow oil
- customThe crude product was purified by column chromatography (SiO2)
- washeluting with 8:2 petrol/ethyl acetate
- customto give a slightly sticky solid which
- customwas further triturated with petroleum spirit (40-60°)
出典と根拠
- ORDレコード
- ord-5e2e2cf38815438bac726ffa7b23f1b6
- 出典データセット
- uspto-grants-2013_09
- 特許番号
- US08536157B2
関連ノート
読み込み中…